Clarity Pharmaceuticals is a biotechnology business based in Australia. Clarity Pharmaceuticals shares (CU6) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Clarity Pharmaceuticals has a trailing 12-month revenue of around $9.8 million. If you're looking to buy shares, check out the steps below.
Our top pick for
Low costs
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $0.675 - $1.505 |
|---|---|
| 50-day moving average | $1.1478 |
| 200-day moving average | $0.9251 |
| Target price | $2.13 |
| PE ratio | 0 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.1 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$1.43
| 1 week (2023-11-30) | 0.35% |
|---|---|
| 1 month (2023-11-07) | 27.68% |
| 3 months (2023-09-07) | 36.19% |
| 6 months (2023-06-07) | 85.71% |
| 1 year (2022-12-07) | 48.19% |
|---|---|
| 2 years (2021-12-07) | 71.26% |
| Revenue TTM | $9.8 million |
|---|---|
| Gross profit TTM | $9.8 million |
| Return on assets TTM | -18.65% |
| Return on equity TTM | -30.48% |
| Profit margin | -251.03% |
| Book value | 0.265 |
| Market capitalisation | $373.4 million |
TTM: trailing 12 months
We're not expecting Clarity Pharmaceuticals to pay a dividend over the next 12 months.
Over the last 12 months, Clarity Pharmaceuticals's shares have ranged in value from as little as $0.675 up to $1.505. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Clarity Pharmaceuticals's is 0.758. This would suggest that Clarity Pharmaceuticals's shares are less volatile than average (for this exchange).
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. Clarity Pharmaceuticals Ltd was incorporated in 2010 and is based in Sydney, Australia.
What you need to know about investing in Shein from Australia.
Looking for the best performing stocks in Australia? We update this list weekly.
If you're thinking of trading stocks with Tiger Brokers, check out our review of this online broker's fees, safety and pros and cons first.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Steps to owning and managing Caltex Australia shares from .
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Learn about the money market and everyday consumer money market products.
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
Follow these tips to find the best share trading platform for you.
